Catheter Precision

Catheter Precision Gross Margin

The Gross Margin of Catheter Precision (VTAK) as of Oct 23, 2026 is 92.31 %. In the previous year, Gross Margin was 90.00 % — a change of 2.56% (higher).

Gross Margin

92.31 %

YoY

2.56%

Last updated:

Gross Margin of Catheter Precision is 2025 92.31 % . Gross Margin of Catheter Precision was 2024 90.00 % . It decreases by 2.56% higher compared to the previous year.

For Catheter Precision, the gross margin of 92.3% is up versus -6,990.9% a few years ago.

The Catheter Precision Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
32.78 USD
Jan 1, 2019
-22.93 USD
Jan 1, 2020
-24.45 USD
Jan 1, 2021
-6,990.91 USD
Jan 1, 2022
-1,050.00 USD
Jan 1, 2023
93.21 USD
Jan 1, 2024
90.00 USD
Jan 1, 2025
92.31 USD
The Catheter Precision Gross Margin history
YEARGross MarginYoY
92.31 %+2.56%
90.00 %-3.45%
93.21 %-108.88%
-1,050.00 %-84.98%
-6,990.91 %+28,493.27%
-24.45 %+6.61%
-22.93 %-169.96%
32.78 %+12.85%
29.05 %-38.84%
47.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Catheter Precision Stock analysis

What does Catheter Precision do? Ra Medical Systems, Inc. generates revenue through the sale of its electrophysiology products Amigo, VIVO, and LockeT to hospitals, physicians, and healthcare providers. The company's Amigo remote catheter system, featuring an open architecture design, allows for versatile use across multiple catheter procedures. VIVO, a non-invasive 3D imaging system, helps physicians identify arrhythmia origins pre-procedure, improving workflow efficiency. LockeT, a suture retention device, supports surgical procedures. These products target cardiac arrhythmia treatment, serving medical institutions and healthcare professionals seeking advanced solutions for patient care. The firm collaborates with physicians to develop and advance its electrophysiology technologies, focusing on improving cardiac arrhythmia procedures. Its product portfolio addresses the need for streamlined workflows and reduced procedure times in electrophysiology settings. Hospitals and physicians purchase these solutions to enhance patient outcomes and operational efficiency in treating vascular immune-mediated inflammatory diseases. The company's commercialization strategy centers on delivering innovative technologies that meet evolving clinical demands in cardiology. Ra Medical Systems, Inc. is engaged in providing new solutions to the market for cardiac arrhythmia treatment, emphasizing technology development for electrophysiology procedures. Its products are designed to improve patient lives through advanced catheter-based systems and imaging solutions. The company's focus on physician collaboration ensures that its offerings align with clinical needs, driving adoption among healthcare providers specializing in cardiac care. Catheter Precision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Catheter Precision stock

Gross Margin of Catheter Precision is 92.31 % in 2025.

Gross Margin of Catheter Precision changed from 90.00 % to 92.31 %, representing a 2.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Catheter Precision since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Catheter Precision with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Catheter Precision

All Key Metrics — Catheter Precision